G. Michael Alder

Develops vaccines and other biological products

Redmont Venture Partners makes early-stage and expansion-stage investments in a variety of sectors including business services, financial services, healthcare, information technology and industrial/manufacturing. They invest in companies in the Southeastern US, with emphasis on Alabama. Redmont looks for companies with stable and predictable earnings and cash flow that have product lines with extended life cycles and low obsolescence risks. They also look for companies with products or services with stable demand and a defensible market position. Companies should have a positive outlook for sales growth and margins and annual or projected near-term revenues of between $3 million and $50 million. Redmont invests in companies that show the need for temporary capital (three to five years) for either business expansion or the execution of a strategic plan. They prefer private companies that are closely-held by owners and/or managers who have a substantial investment in the company and are lead by a talented, experienced management team. Minimum investment size is $500,000 with total investments ranging from $1.5 million to $2.5 million. Deals are structured as equity through either preferred stock or membership or as debt including senior and/or subordinated.

Provides biomedical research services

Operates as non-classified establishment

Functions as a College/University